Trend Revising? Biotech IPOs Slow Sharply In HK While Shanghai's STAR Shines

 
• By Brian Yang
Hong Kong
CHINESE BIOTECHS POSTPONE HONG KONG IPOS AMID LOW VALUATIONS, SHANGHAI COMPETITION • Source: Shutterstock

More from Financing

More from Business